annoucement

Company Update (NASDAQ:CYTX): Cytori Therapeutics Inc Completes Enrollment in US Phase IIb Osteoarthritis Trial

By Corey Williams Cytori Therapeutics Inc (NASDAQ:CYTX) announced that enrollment has been completed in its US Phase IIb Osteoarthritis trial. The…